NDC 63629-5074-01 - Buprenorphine HCl and Naloxone HCl
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-5074
- Requested NDC
- 63629-5074-01
- Package NDCs from labels
- 63629-5074-1, 63629-5074-2, 63629-5074-3, 63629-5074-4, 63629-5074-5, 63629-5074-6, 63629-5074-7, 63629-5074-8, 63629-5074-9, 63629-5074-0, 63629-5074-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Buprenorphine HCl and Naloxone HCl - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-04-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-5074-0 | Buprenorphine HCl and Naloxone HCl | 42 in 1 BOTTLE | TABLET | 42 | 1007 | |
| 63629-5074-1 | Buprenorphine HCl and Naloxone HCl | 30 in 1 BOTTLE | TABLET | 30 | 1007 | |
| 63629-5074-2 | Buprenorphine HCl and Naloxone HCl | 60 in 1 BOTTLE | TABLET | 60 | 1007 | |
| 63629-5074-3 | Buprenorphine HCl and Naloxone HCl | 90 in 1 BOTTLE | TABLET | 90 | 1007 | |
| 63629-5074-4 | Buprenorphine HCl and Naloxone HCl | 120 in 1 BOTTLE | TABLET | 120 | 1007 | |
| 63629-5074-5 | Buprenorphine HCl and Naloxone HCl | 14 in 1 BOTTLE | TABLET | 14 | 1007 | |
| 63629-5074-6 | Buprenorphine HCl and Naloxone HCl | 28 in 1 BOTTLE | TABLET | 28 | 1007 | |
| 63629-5074-7 | Buprenorphine HCl and Naloxone HCl | 6 in 1 BOTTLE | TABLET | 6 | 1007 | |
| 63629-5074-8 | Buprenorphine HCl and Naloxone HCl | 10 in 1 BOTTLE | TABLET | 10 | 1007 | |
| 63629-5074-9 | Buprenorphine HCl and Naloxone HCl | 21 in 1 BOTTLE | TABLET | 21 | 1007 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-5074 | BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE) TABLET [BRYANT RANCH PREPACK] | 1006 | Current NDC, 10 package rows | 20240518_2aaad1a7-a0fd-4dd5-bb53-03afad8f10b9.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BUPRENORPHINE | BUPRENORPHINE | Unit Dose Solutions, Inc. | 5578cd5c-c860-6e8a-e063-6394a90a56c7 | 2026-06-30 | Warnings, Adverse reactions | 56W8MW3EN1 |
| BUPRENORPHINE | BUPRENORPHINE | Bryant Ranch Prepack | aa132031-9d12-45b4-81e0-4a5877661379 | 2026-06-29 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine | BUPRENORPHINE | Bryant Ranch Prepack | 655e3e52-03be-496c-978a-5cffc74b2ae4 | 2026-06-29 | Warnings, Adverse reactions | 56W8MW3EN1 |
| BUPRENORPHINE AND NALOXONE | BUPRENORPHINE AND NALOXONE | Ascend Laboratories, LLC | 2e807ed0-6df3-47b5-b7ee-b421c5bf0aa7 | 2026-06-29 | Warnings, Adverse reactions | 351266 351267 56W8MW3EN1 |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | 1Q73Q2JULR | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | 1Q73Q2JULR | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | 1Q73Q2JULR | |
| Rohto Sun and Sport | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 8bcc8882-b886-4b55-9bc4-d4b92a41358f | 2026-06-19 | Warnings | FZ989GH94E |
| Rohto Dual Light Relief | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 1b597f83-d7f1-cf93-e063-6394a90a99f7 | 2026-06-19 | Warnings | FZ989GH94E |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Bryant Ranch Prepack | 2063d5bf-b3bc-4e73-9046-7e994446ab50 | 2026-06-18 | Warnings, Adverse reactions | 351267 |
| BUPRENORPHINE | BUPRENORPHINE | Unit Dose Solutions, Inc. | 5479b218-a388-2c3c-e063-6294a90a0e85 | 2026-06-17 | Warnings, Adverse reactions | 56W8MW3EN1 |
| BUPRENORPHINE | BUPRENORPHINE | Bryant Ranch Prepack | 966adb01-71b4-4e0b-bbc6-b83da9987aa2 | 2026-06-16 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine | BUPRENORPHINE | Major Pharmaceuticals | dba586f9-e3f2-4b9c-849b-907c81a5a0ef | 2026-06-16 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Bryant Ranch Prepack | fe023dbf-e165-4b7f-a211-bd14696f1e2c | 2026-06-16 | Warnings, Adverse reactions | 351267 5Q187997EE 56W8MW3EN1 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Bryant Ranch Prepack | 4b1df792-f56c-4c0c-92b0-a887f4225567 | 2026-06-16 | Warnings, Adverse reactions | 351266 5Q187997EE 56W8MW3EN1 |
| E-Z-GAS II | ANTACID/ANTIFLATULENT | E-Z-EM, INC. | 4e12e1cb-b033-076d-e054-00144ff8d46c | 2026-06-15 | Warnings | XF417D3PSL |
| Buprenorphine and Naloxone Sublingual Film | BUPRENORPHINE AND NALOXONE | Redpharm Drug | 541bf5be-8b2c-99bc-e063-6294a90a2f17 | 2026-06-13 | Warnings, Adverse reactions | 5Q187997EE 56W8MW3EN1 |
| Zubsolv | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | Edenbridge Pharmaceuticals LLC. | 57583c1d-9c44-4503-917d-68dba7377bd1 | 2026-06-12 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Bryant Ranch Prepack | 17419c34-23a3-429c-8037-150f42536ec7 | 2026-06-12 | Warnings, Adverse reactions | 351267 5Q187997EE 56W8MW3EN1 |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Cardinal Health 107, LLC | b3d5225c-0ee4-481e-b9ec-bc5e1321096d | 2026-06-12 | Adverse reactions | 1Q73Q2JULR XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.